Search - tctmd.com

Displaying 741 - 760 of 785

Sort: Relevancy | Date

News Features

We Asked, You Answered: Exercise by the Numbers

Yael L. Maxwell

October 26, 2016

News Daily News

FDA Classifies Latest HeartWare VAD Recalls as Class I

Michael O'Riordan

October 24, 2016

News Daily News

Minnesota’s Device Companies Pumping Money into Congressional Race to Re-Elect Their Champion

Michael O'Riordan

October 12, 2016

News Daily News

Vascular Solutions 召回双通双通路导管

Michael O'Riordan

October 06, 2016

News Daily News

Vascular Solutions Retira los Catéteres Gemelos de Doble Vía

Michael O'Riordan

October 06, 2016

News Daily News

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

Michael O'Riordan

October 06, 2016

News Features

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Michael O'Riordan

October 05, 2016

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

太多主角：不同指南 CVD 风险评估存在混淆和不一致

Michael O'Riordan

September 16, 2016

News Daily News

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Michael O'Riordan

September 16, 2016

News Daily News

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Michael O'Riordan

September 16, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Daily News

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Michael O'Riordan

September 13, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

尽管有战乱和冲突，但缺血性心脏病的死亡率仍然迎来了“阿拉伯之春”

Michael O'Riordan

August 26, 2016

News Daily News

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

Michael O'Riordan

August 26, 2016

News Daily News

A pesar de la Muerte y las Penurias, la Cardiopatía Isquémica es la Principal Causa de Muerte en la ‘Primavera Árabe’

Michael O'Riordan

August 26, 2016

News Daily News

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

Michael O'Riordan

August 18, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

Advertisement

We Asked, You Answered: Exercise by the Numbers

FDA Classifies Latest HeartWare VAD Recalls as Class I

Minnesota’s Device Companies Pumping Money into Congressional Race to Re-Elect Their Champion

Vascular Solutions 召回双通双通路导管

Vascular Solutions Retira los Catéteres Gemelos de Doble Vía

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

太多主角：不同指南 CVD 风险评估存在混淆和不一致

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

尽管有战乱和冲突，但缺血性心脏病的死亡率仍然迎来了“阿拉伯之春”

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

A pesar de la Muerte y las Penurias, la Cardiopatía Isquémica es la Principal Causa de Muerte en la ‘Primavera Árabe’

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content